{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:05:51Z","timestamp":1792829151281,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.molmed.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T12:43:34Z","timestamp":1726922614000},"page":"106-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fibrodysplasia ossificans progressiva emerges from obscurity"],"prefix":"10.1016","volume":"31","author":[{"given":"Frederick S.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.08.010_bb0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.08.010_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/437491a","article-title":"A new grammar for drug discovery","volume":"437","author":"Fishman","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.08.010_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0020","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.08.010_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2017.11.014","article-title":"Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bone.2017.06.011","article-title":"The obligatory role of Activin A in the formation of heterotopic bone in fibrodysplasia ossificans progressiva","volume":"109","author":"Alessi Wolken","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0035","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"29","author":"Di Rocco","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0040","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106317","article-title":"Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation","volume":"40","author":"Ramachandran","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.08.010_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/cells13030221","article-title":"The activation of the fibrodysplasia ossificans progressiva-inducing ALK2-R206H mutant depends on the distinct homo-oligomerization patterns of ACVR2B and ACVR2A","volume":"13","author":"Szil\u00e1gyi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2024.08.010_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/biom14030357","article-title":"Immunologic aspects in fibrodysplasia ossificans progressiva","volume":"14","author":"Diolintzi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2024.08.010_bb0055","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0060","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2017.08.023","article-title":"Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Brennan","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of mast cells and macrophages impairs heterotopic ossification in an Acvr1R206H mouse model of fibrodysplasia ossificans progressiva","volume":"33","author":"Convente","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bone.2017.12.024","article-title":"ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122958","article-title":"NF-\u03baB\/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification","volume":"3","author":"Barruet","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2024.08.010_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116129","article-title":"ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages","volume":"153","author":"Matsuo","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.4492","article-title":"Plasma-soluble biomarkers for fibrodysplasia ossificans progressiva (FOP) reflect acute and chronic inflammatory states","volume":"37","author":"Pignolo","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0095","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1073\/pnas.1515397113","article-title":"Inhibition of Hif1\u03b1 prevents both trauma-induced and genetic heterotopic ossification","volume":"113","author":"Agarwal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.08.010_bb0100","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/dvg.20201","article-title":"Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2","volume":"44","author":"Fukuda","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.molmed.2024.08.010_bb0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2017.07.019","article-title":"Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases","volume":"109","author":"Kaplan","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116016","article-title":"Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva","volume":"150","author":"Kaplan","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0120","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI93521","article-title":"Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva","volume":"127","author":"Hino","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.08.010_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/biom14020147","article-title":"The HIF-1\u03b1 and mTOR pathways amplify heterotopic ossification","volume":"14","author":"Wang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2024.08.010_bb0130","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302219","article-title":"Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva","volume":"7","author":"Sun","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.molmed.2024.08.010_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115978","article-title":"Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients","volume":"149","author":"Wang","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2024.08.010_bb0145","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jbmr.3760","article-title":"Elevated BMP and mechanical signaling through YAP1\/RhoA poises FOP mesenchymal progenitors for osteogenesis","volume":"34","author":"Stanley","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ydbio.2020.11.004","article-title":"Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP)","volume":"470","author":"Towler","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2024.08.010_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.612853","article-title":"The developmental phenotype of the great toe in fibrodysplasia ossificans progressiva","volume":"8","author":"Towler","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2024.08.010_bb0160","first-page":"164","article-title":"BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP)","volume":"25","author":"Towler","year":"2022","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.molmed.2024.08.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115116","article-title":"Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva","volume":"130","author":"Towler","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115539","article-title":"Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis","volume":"140","author":"Kaplan","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.08.010_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2106\/JBJS.F.00472","article-title":"Hematopoietic stem-cell contribution to ectopic skeletogenesis","volume":"89","author":"Kaplan","year":"2007","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.molmed.2024.08.010_bb0180","first-page":"3462","article-title":"The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization","volume":"119","author":"Shen","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.08.010_bb0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/stem.1633","article-title":"Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification","volume":"32","author":"Culbert","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2024.08.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.08.010_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41536-021-00201-8","article-title":"Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressiva","volume":"7","author":"Stanley","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/biomedicines12040779","article-title":"Cellular and molecular mechanisms of heterotopic ossification in fibrodysplasia ossificans progressiva","volume":"12","author":"Mejias Rivera","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmed.2024.08.010_bb0210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2106\/JBJS.G.00774","article-title":"Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva","volume":"90","author":"Deirmengian","year":"2008","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.molmed.2024.08.010_bb0215","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1359\/jbmr.2003.18.9.1593","article-title":"ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development","volume":"18","author":"Zhang","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2233","article-title":"A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification","volume":"13","author":"Cong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/biom14030347","article-title":"Hedgehog signaling controls chondrogenesis and ectopic bone formation via the Yap-Ihh axis","volume":"14","author":"Cong","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2024.08.010_bb0230","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.1603668113","article-title":"BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16\/INK4A-dependent senescence","volume":"113","author":"Hayashi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.08.010_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jbmr.4458","article-title":"Clearance of senescent cells from injured muscle abrogates heterotopic ossification in mouse models of fibrodysplasia ossificans progressiva","volume":"37","author":"Wang","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0240","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00415-012-6562-y","article-title":"Neurological symptoms in individuals with fibrodysplasia ossificans progressiva","volume":"259","author":"Kitterman","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.molmed.2024.08.010_bb0245","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/jcb.23259","article-title":"Substance P signaling mediates BMP-dependent heterotopic ossification","volume":"112","author":"Kan","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2024.08.010_bb0250","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s00415-012-6563-x","article-title":"CNS demyelination in fibrodysplasia ossificans progressiva","volume":"259","author":"Kan","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.molmed.2024.08.010_bb0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-021-01709-4","article-title":"Suppressed prefrontal cortex oscillations associate with clinical pain in fibrodysplasia ossificans progressiva","volume":"16","author":"Peng","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.molmed.2024.08.010_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/j.pain.0000000000002656","article-title":"ACVR1-activating mutation causes neuropathic pain and sensory neuron hyperexcitability in humans","volume":"164","author":"Yu","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.molmed.2024.08.010_bb0265","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/jbmr.4711","article-title":"Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1R206H -specific human cellular and zebrafish models","volume":"37","author":"Wentworth","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0270","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jbmr\/zjae029","article-title":"MMP-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice","volume":"39","author":"Lounev","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jbmr\/zjae044","article-title":"Actionable disease insights from bedside-to-bench investigation in fibrodysplasia ossificans progressiva","volume":"39","author":"Wein","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-019-0386-6","article-title":"Is fibrodysplasia ossificans progressiva an interleukin-1 driven auto-inflammatory syndrome?","volume":"17","author":"Haviv","year":"2019","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.molmed.2024.08.010_bb0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12969-023-00856-1","article-title":"Successful experience of tofacitinib treatment in patients with fibrodysplasia ossificans progressiva","volume":"21","author":"Nikishina","year":"2023","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.molmed.2024.08.010_bb0290","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95042","article-title":"Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva","volume":"6","author":"Williams","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2024.08.010_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp8334","article-title":"An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva","volume":"16","author":"Davis","year":"2024","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0305","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/jbmr.4617","article-title":"Overexpression of wild-type ACVR1 in fibrodysplasia ossificans progressiva mice rescues perinatal lethality and inhibits heterotopic ossification","volume":"37","author":"Yamamoto","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0310","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/s41467-022-33956-9","article-title":"Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.08.010_bb0315","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/biom13091364","article-title":"AAV-mediated targeting of the Activin A-ACVR1R206H signaling in fibrodysplasia ossificans progressiva","volume":"13","author":"Yang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2024.08.010_bb0320","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2024.08.010_bb0325","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm.2334","article-title":"Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-\u03b3 agonists","volume":"17","author":"Shimono","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0330","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jbmr.4762","article-title":"Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP)","volume":"38","author":"Pignolo","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/biom14030349","article-title":"Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification","volume":"14","author":"Juan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2024.08.010_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41422-023-00918-9","article-title":"The roles and regulatory mechanisms of TGF-\u03b2 and BMP signaling in bone and cartilage development, homeostasis and disease","volume":"34","author":"Wu","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0345","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nm0898-882","article-title":"Self-organization, complexity and chaos: the new biology for medicine","volume":"4","author":"Coffey","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.08.010_bb0350","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classical and atypical FOP phenotypes are caused by mutations in the BMP type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2024.08.010_bb0355","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva: a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2024.08.010_bb0360","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva. An endochondral process","volume":"75","author":"Kaplan","year":"1993","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.molmed.2024.08.010_bb0365","first-page":"103","article-title":"Compartment Syndrome of the Thigh in a Patient with Fibrodysplasia Ossificans Progressiva","volume":"10","author":"Kaplan","year":"2020","journal-title":"J. Orthop. Case Reps."},{"key":"10.1016\/j.molmed.2024.08.010_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/21678707.2020.1751122","article-title":"Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva","volume":"8","author":"Pignolo","year":"2020","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.molmed.2024.08.010_bb0375","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.molmed.2024.08.010_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000365770","article-title":"Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation","volume":"5","author":"H\u00fcning","year":"2014","journal-title":"Mol. Syndromol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:46:51Z","timestamp":1739375211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1471491424002387"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.08.010","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrodysplasia ossificans progressiva emerges from obscurity","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}